Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
; : 202-211, 2017.
Article
in En
| WPRIM
| ID: wpr-786940
Responsible library:
WPRO
ABSTRACT
Prostate-specific membrane antigen (PSMA) is an attractive target for both diagnosis and therapy because of its high expression in the vast majority of prostate cancers. Development of small molecules for targeting PSMA is important for molecular imaging and radionuclide therapy of prostate cancer. Recent evidence implies that androgendeprivation therapy increase PSMA-ligand uptake in some cases. The reported upregulations in PSMA-ligand uptake after exposure to second-generation antiandrogens such as enzalutamide and abiraterone might disturb PSMA-targeted imaging for staging and response monitoring of patients undergoing treatment with antiandrogen-based drugs. On the other hand, second-generation antiandrogens are emerging as potential endoradio-/chemosensitizers. Therefore, the enhancement of the therapeutic efficiency of PSMA-targeted theranostic methods can be listed as a new capability of antiandrogens. In this manuscript, we will present what is currently known about the mechanism of increasing PSMA uptake following exposure to antiandrogens. In addition, we will discuss whether these above-mentioned antiandrogens could play the role of endoradio-/chemosensitizers in combination with the well-established PSMA-targeted methods for pre-targeting of prostate cancer.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Prostatic Neoplasms
/
Positron-Emission Tomography
/
Diagnosis
/
Molecular Imaging
/
Theranostic Nanomedicine
/
Hand
/
Androgen Antagonists
/
Membranes
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Korean Journal of Nuclear Medicine
Year:
2017
Type:
Article